Apart from the relevant diagnostic issue of the exclusion of prion disease (Abu-Rumeileh et al., 2019a), CSF and blood NfL have been explored in AE as easily accessible tools for disease monitoring, prognosis, and response to therapy. This evidence concerns the gene NEFL and prion disease.